GSE183535 MYC inhibition HeLa 3 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE183535_MYC inhibition_HeLa_3_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE183535_MYC inhibition_HeLa_3_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE183535_MYC inhibition_HeLa_3_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE183535_MYC inhibition_HeLa_3_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 17

Gene

VPS9D1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 3040

Gene

long intergenic non-protein coding RNA 1128

Gene

MIR137 host gene

Gene

SDHA pseudogene 4

Gene

protocadherin beta 17 pseudogene

Gene

leucine rich repeat containing 37 member A6, pseudogene

Gene

AQP4 antisense RNA 1

Gene

TERT regulating lncRNA 1

  • Gene

    small nucleolar RNA host gene 17


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    long intergenic non-protein coding RNA 1128



  • Gene

    SDHA pseudogene 4


  • Gene

    protocadherin beta 17 pseudogene


  • Gene

    leucine rich repeat containing 37 member A6, pseudogene


  • Gene

    AQP4 antisense RNA 1


  • Gene

    TERT regulating lncRNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.